The predictive power of free (vs. total) testosterone in aggressive prostate cancer.

被引：0
|
作者：
Towe, Maxwell M. [1 ]
Huynh, Linda My [1 ]
El Khatib, Farouk [1 ]
Osman, Mohamad M. [1 ]
Yafi, Faysal A. [1 ]
Ahlering, Thomas Edward [1 ]
机构：
[1] Univ Calif Irvine, Orange, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e16570
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16570
引用
收藏
页数：2
相关论文
共 50 条
  • [31] FREE SERUM TESTOSTERONE VERSUS TOTAL TESTOSTERONE AS SURROGATE MARKER FOR THE CLINICAL BENEFIT OF ANDROGEN SUPPRESSION IN PROSTATE CANCER PATIENTS
    Regis, Lucas
    Iztueta, Ignacio
    Servian, Pol
    Kosntantinidis, Cristian
    Planas, Jacques
    Celma, Ana
    Placer, Jose
    DeTorres, Ines
    Morote, Juan
    JOURNAL OF UROLOGY, 2014, 191 (04): : E856 - E856
  • [32] CONTINUOUS BPH FINASTERIDE THERAPY VS. INTERMITTENT TREATMENT: THE UPGRADE OF NED AND THUS OF AGGRESSIVE PROSTATE CANCER
    Tarle, M.
    Spajic, B.
    Kraljic, I.
    Ruzic, B.
    Reljic, A.
    Kusic, Z.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3511 - 3512
  • [33] THE RELATIONSHIP BETWEEN TOTAL AND FREE SERUM TESTOSTERONE AND THE RISK OF PROSTATE CANCER AND TUMOUR AGGRESSIVENESS - Reply
    Morote, Juan
    BJU INTERNATIONAL, 2010, 105 (02) : 281 - 281
  • [34] ANDROGEN LEVELS AND HIGH-GRADE PROSTATE CANCER: FREE TO TOTAL TESTOSTERONE RATIO ANALYSIS
    Albisinni, Simone
    De Nunzio, Cosimo
    Tubaro, Andrea
    Banez, Lionel
    Freedland, Stephen J.
    ANTICANCER RESEARCH, 2011, 31 (05) : 1812 - 1812
  • [35] Re: Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2018, 199 (03): : 610 - 610
  • [36] Re: Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer
    Penson, David F.
    JOURNAL OF UROLOGY, 2018, 199 (01): : 19 - 19
  • [37] Surgery vs. 'watchful waiting' in prostate cancer
    不详
    AMERICAN JOURNAL OF NURSING, 2002, 102 (12) : 19 - 19
  • [38] A randomized phase IIb presurgical study of finasteride vs. low-dose flutamide vs. placebo in men with prostate cancer. Efficacy monitored by karyometry
    Montironi, Rodolfo
    Bartels, Peter H.
    DeCensi, Andrea
    Puntoni, Matteo
    Hurle, Rodolfo
    Decobelli, Ottavio
    Carmignani, Giorgio
    Mazzucchelli, Roberta
    Bartels, Hubert G.
    Alberts, David S.
    Maffezzini, Massimo
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2013, 31 (05) : 557 - 565
  • [39] The preoperative serum ratio of total prostate specific antigen (PSA) to free testosterone (FT), PSA/FT index ratio, and prostate cancer. Results in 220 patients undergoing radical prostatectomy
    Porcaro, Antonio B.
    Caruso, Beatrice
    Terrin, Alessandro
    De Luyk, Nicolo
    Cacciamani, Giovanni
    Corsi, Paolo
    Inverardi, Davide
    De Marchi, Davide
    Baldassarre, Roberto
    Cerruto, Mariangela
    Ghimenton, Claudio
    Brunelli, Matteo
    Antoniolli, Stefano Zecchini
    Petrozziello, Aldo
    Artibani, Walter
    ARCHIVIO ITALIANO DI UROLOGIA E ANDROLOGIA, 2016, 88 (01) : 17 - +
  • [40] PSA and free testosterone: An inverse correlation in prostate cancer
    Jamal, Joseph E.
    Kwon, Eric O.
    Bruno, J. James, II
    Armenakas, Noel A.
    Fracchia, John A.
    JOURNAL OF UROLOGY, 2007, 177 (04): : 572 - 573
12345